All National Center for Cardiovascular Diseases articles
-
NewsOral chiral nanozyme protects the heart during chemotherapy by reshaping the gut-heart axis
A chirality-engineered nanozyme restores gut microbiota and host metabolism to prevent doxorubicin-induced cardiotoxicity without compromising anticancer efficacy.